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Available online 23 September 2011Background: This study assessed the association between Type D personality (the conjoint ef-
fect of negative affectivity and social inhibition) and quality of life (QoL) and mental health of
cancer survivors up to 10 years post-diagnosis.
Methods: All currently alive individuals diagnosed with endometrial or colorectal cancer be-
tween 1998 and 2007, or with lymphoma or multiple myeloma between 1999 and 2008 as
registered in the Eindhoven Cancer Registry received a questionnaire on Type D personality
(DS14), QoL (SF-36 or EORTC-QLQ-C30) and mental health (HADS).
Results: Of the 3080 survivors who responded (69%), 572 (19%) had a Type D personality. Type D
survivors had clinicallymeaningful lower levels of general health, social functioning, role-function
emotional, mental health and vitality compared to non-Type D's (SF-36: all P'sb0.001). They also
reported clinically meaningful worse emotional and social functioning, global health status/QoL,
andmore fatigue (EORTC-QLQ-C30: all P'sb0.001). Thiswas also confirmed bymultivariate logis-
tic regression analyses showing that cancer survivors with a Type D personality were more likely
to experience a decreased QoL on all SF-36 and EORTC-QLQ-C30 scales (all ORs ranging between
1.88 and 5.56). The proportion of survivors reporting an impaired QoL was higher among Type D
(35–64%) than non-TypeD's (20–36%). Finally, TypeD'sweremore likely to be depressed (44% vs.
13%; Pb0.0001) or anxious (51% vs. 14%; Pb0.0001).
Conclusions: Cancer survivors with a Type D personality are at increased risk of impaired QoL and
mental health problems that cannot be explained by socio-demographic or clinical characteristics.
© 2011 Elsevier B.V. Open access under the Elsevier OA license.Keywords:
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The prevalence of cancer is rising due to the increasing in-
cidence of cancer in general, the aging of the population, and
more effective treatments (Signaleringscommissie-Kanker,
2004). This has lead to an increasing number of individualsCR, Eindhoven Cancer
e; HRQL, health relat-
edical Psychology and
5000 LE Tilburg, The
ols).
lsevier OA license.who are cured of their cancer or are living with it as a chronic
disease (Ganz, 2009). Many of those survivors face continu-
ing physical and mental problems due to cancer and its
treatment.
Most survivorship studies focus on the role of clinical
variables to explain differences in quality of life (QoL) between
patients (Mols et al., 2006, 2008; van de Poll-Franse et al.,
2007). However, there is still a significant gap in our under-
standing of the determinants of QoL and mental health status
outcomes; the role of individual differences is under exposed.
In addition to fighting the disease itself, the patient's personal
mental management of the stresses associated with cancer is
equally important (Spiegel, 2011). The holy grail of personalized
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tional research, also implies that we can find better ways to
identify those patients at risk for impaired QoL and mental
health status. Individual differences in personality are impor-
tant in this context.
In the cardiovascular field, Type D (distressed) personality
has become an important research topic in recent years. Type
D personality has been described as the tendency to experi-
ence a high joint occurrence of negative affectivity and social
inhibition (Denollet, 2005). People that score high on nega-
tive affectivity have the tendency to experience negative
emotions, while people that score high on social inhibition
have the tendency not to express these emotions, because
of fear of rejection or disapproval by others. Persons with
high levels on both personality traits are classified as having
a Type D personality (Denollet, 2005). Systematic reviews
among cardiovascular patients (Denollet et al., 2010), non-
cardiovascular patients (Mols and Denollet, 2010a), and
healthy individuals (Mols and Denollet, 2010b) have shown
that personality is a stable (Denollet, 2005) and powerful
predictor of impaired QoL and mental health status, above
and beyond clinical characteristics. However, studies on
Type D personality among cancer survivors are scarce (Mols
et al., 2010a). Therefore, the goal of this study was to exam-
ine whether Type D personality was associated with an in-
creased risk of impaired QoL and mental health status
among survivors of endometrial cancer, colorectal cancer,
lymphoma or multiple myeloma.2. Methods
2.1. Setting and participants
This secondary analysis used data from four large popula-
tion-based longitudinal surveys on survivors of endometrial
cancer, colorectal cancer, lymphoma and multiple myeloma.
These studies were set up in 2008/2009 using data from the
Eindhoven Cancer Registry (ECR), and were designed to eval-
uate various patient-reported outcomes (e.g. late effects,
physical and mental health status) among cancer survivors.
The ECR compiles data of all individuals newly diagnosed
with cancer in the southern part of the Netherlands, an area
with 10 hospitals serving 2.3 million inhabitants (Janssen-
Heijnen et al., 2005). All individuals diagnosed with endome-
trial cancer or colorectal cancer from 1998 to 2007, and all in-
dividuals diagnosed with Hodgkin or non-Hodgkin lymphoma
or multiple myeloma from 1999 to 2008 as registered in the
ECR were eligible for participation. However due to the large
number of colorectal cancer survivors (n=5399) a weighted
random selection of 2219 patients based on tumor, sex, and
year of diagnosis was made (Thong et al., 2011a; Thong et al.,
2011b). The weights on tumor and sex were derived from the
total distribution of colorectal cancer survivors in the ECR re-
gion. Patients with fewer years since diagnosis were over-
sampled for inclusion in future follow-up assessments.
After excluding those patients who had cognitive impair-
ment, had died prior to start of study (according to the ECR,
the Central Bureau for Genealogy which collects information
on all deceased Dutch citizens via the civil municipal regis-
tries, and hospital records) or had unverifiable addresses,data collection started in 2008–2009. All studies were ap-
proved by a Medical Ethics Committee.
2.2. Data collection
Survivors were informed of the study via a letter from
their (ex)-attending specialist. The letter explained that by
completing and returning the enclosed questionnaire, pa-
tients consented to participate in the study and agreed to
the linkage of the questionnaire data with their disease histo-
ry in the ECR. Patients were reassured that non-participation
had no consequences on their follow-up care or treatment.
Non-respondents were sent a reminder letter and question-
naire within 2 months.
Survivors' sociodemographic and clinical information
were available from the ECR which routinely collects data
like date of diagnosis, tumor grade (1992), clinical stage
(1992), treatment, and comorbidity at the time of diagnosis.
Comorbidity at the time of the study was assessed with the
adapted Self-administered Comorbidity Questionnaire (Sangha
et al., 2003). Socioeconomic status was determined by an indi-
cator developed by Statistics Netherlands (van Duijn and Keij,
2002). Questions on marital status, educational level, and cur-
rent occupation were added to the questionnaire.
2.3. Type D personality
Type D personality was measured with the 14-item Type
D Personality Scale (DS14) (Denollet, 2005). The DS14 is
self-administered and takes only a few minutes to complete.
The 14 items of this scale are answered on a 5-point response
scale ranging from 0 (false) to 4 (true). Seven of these items
refer to “Negative Affectivity” or the tendency to experience
negative emotions in general. The remaining 7 items refer
to the patient's level of “Social Inhibition” or the tendency
to inhibit the expression of emotions in social relationships.
Patients were categorized as Type D using a standardized
cut-off score of ≥10 on both the negative affectivity and so-
cial inhibition subscales, following the protocol as previously
established (Denollet, 2005). The DS14 is a valid and reliable
scale with Cronbach's α of 0.88/0.86 and a test–retest reli-
ability over a 3-month period of r=0.72/0.82 for the two
subscales, respectively (Denollet, 2005).
2.4. Quality of life
To evaluate the quality of life of cancer survivors included
in this study, we used the SF-36 or the EORTC-QLQ-C30.
In the two studies on colorectal and endometrial cancer sur-
vivors, the Dutch version of the SF-36 questionnaire was used
to assess QoL (Aaronson et al., 1998). This questionnaire incor-
porates 8 domains: general health, physical functioning, role
function-physical, bodily pain, vitality, social functioning, role
function-emotional, and mental health (Aaronson et al.,
1998). According to standard scoring procedures, the subscales
were linearly converted to a 0–100 scale, with higher scores in-
dicating better functioning.
The EORTC-QLQ-C30 (Version 3.0), a 30-item self-report
questionnaire, was used in our cohorts of lymphoma and multi-
ple myeloma survivors to assess cancer-specific QoL (Niezgoda
and Pater, 1993). It contains five functional scales on physical,
28 F. Mols et al. / Journal of Affective Disorders 136 (2012) 26–34role, cognitive, emotional and social functioning, a global health
status/QoL scale, three symptoms scales on fatigue, nausea and
vomiting, and pain, and six single items assessing dyspnea, in-
somnia, loss of appetite, constipation, diarrhea, and financial im-
pact. Each item is scored in one of four categories ranging from1)
not at all to 4) very much, except for the global QoL scale, which
ranges from 1) very poor to 7) excellent. Scores were linear
transformed to a 0–100 scale (Fayers et al., 2001); a higher
score on the functional scales and global QoL means better func-
tioning and QoL, whereas a higher score on the symptom scales
mean more complaints.
2.5. Mental health
Mental health was operationalized by anxiety and depres-
sion. The Hospital Anxiety and Depression Scale (HADS) is a
self-report questionnaire comprising 14 items on a four-point
Likert-scale; 7 for depression and 7 for anxiety (Zigmond and
Snaith, 1983). It assesses levels of symptoms in the last week.
The depression subscale mainly covers anhedonia and loss of in-
terest, which are core depressive symptoms, while the anxiety
subscale covers the core anxiety features ofworry and tenseness.
We used a score of 8 as a cut-off value for both depression and
anxiety (Olsson et al., 2005; Zigmond and Snaith, 1983).
2.6. Statistical analyses
Routinely collected data from the ECR on patient and cancer
characteristics enabled us to compare the group of respondents,
non-respondents and patientswith unverifiable addresses, using
t-tests for continuous variables and chi-square analyses for cate-
gorical variables. Differences between patients with andwithout
a Type D personality in sociodemographic and clinical character-
istics were analyzed in a similar way.
The SF-36 and EORTC-QLQ-C30 mean scores, stratified by
Type D personality, were compared with analysis of covariance
(ANCOVA). Confounding background variables included for ad-
justment in these analyses were determined a priori (Babyak,
2004) and chosen to be age and comorbidity at time of question-
naire. Clinically meaningful differences were determined withTable 1
Demographic and clinical characteristics of respondents, non-respondents and pati
N (%)
Respondents Non-resp
N=3080
(69.3%)
N=863
(19.4%)
Cancer type
Endometrial cancer 741 (24.1) 224 (26.0
Colorectal cancer 1353 (43.9) 380 (44.0
Lymphoma 866 (28.1) 219 (25.4
Multiple Myeloma 120 (3.9) 40 (4.6)
Age (at time of survey) (mean±SD) 66.2±11.5 67.7±12
Years since diagnosis (mean±SD) 4.6±2.5 4.6±2.6
Gender
Male 1349 (43.8) 325 (37.7
Female 1731 (56.2) 538 (62.3
Treatment
Surgery 2083 (67.6) 591 (68.5
Radiotherapy 810 (26.4) 178 (20.9
Chemotherapy 1044 (34.0) 243 (28.5Norman's ‘rule of thumb’, whereby a difference of≈0.5 SD indi-
cates a threshold of discriminant change in health status scores
of a chronic illness (Norman et al., 2003). In secondary analyses,
we additionally controlled for cancer type and depression. Also,
we performed ANCOVAs on the SF-36 and EORTC-QLQ-C30
mean scores, stratifiedbyTypeDpersonality, for the three largest
tumor groups separately. Finally, the SF-36 mean scores, strati-
fied by 1) those with a Type D personality, 2) those with a high
score (≥10) on negative affectivity, and 3) those with a low
score (b10) on negative affectivity, were compared with
ANCOVA. Again, confounding background variables included
for adjustment in these analyses were determined a priori
(Babyak, 2004) and chosen to be age and comorbidity at time
of questionnaire.
In addition, multiple logistic regression analyses were per-
formed to evaluate the adjusted relationship between QoL (‘im-
paired’ QoL as reference group) and Type D personality,
controlling for age, gender and comorbidity (Babyak, 2004). In
order to perform these analyses, all SF-36 subscales and the
EORTC-QLQ-C30 function scales were dichotomized with ‘im-
paired’ QoL (coded as 1) being N0.5 SD below the mean, while
‘good’ quality of life (coded as 0) was defined as all other scores
(Norman et al., 2003). This rule of N0.5 SD below the mean
was chosen because, unlike many questionnaires-specific
rules for impaired QoL, it can be used for both the SF-36
and EORTC-QLQ-C30 questionnaire. This rule of thumb for
an ‘impaired’ QoL is quite comparable to a small to medium
difference with respect to QoL as recently defined for the
EORTC-QLQ-C30 (Cocks et al., 2011).
All statistical test were two-sided and considered significant
if Pb0.01. All statistical analyses were performed using SAS
(version 9.2 for Windows, SAS institute Inc., Cary NC).
3. Results
3.1. Demographic and clinical characteristics
Sixty-nine percent of the 4454 cancer survivors returned
a completed questionnaire. In general, respondents, non-
respondents andpatientswithnon-verifiable addresses differedents who were lost to follow-up.
P-value
ondents Patients with unveriﬁable addresses
N=503
(11.3%)
b0.0001
) 126 (25.1)
) 150 (29.8)
) 202 (40.2)
25 (5.0)
.8 63.2±14.6 b0.0001
5.0±2.6 0.0046
0.0051
) 209 (41.6)
) 294 (58.5)
) 275 (54.7) b0.0001
) 122 (24.5) 0.0043
) 178 (35.7) 0.0045
Table 2
Sociodemographic and clinical characteristics of cancer survivors.
N (%) P-value
Type D
N=572
(19%)
Non-type D
N=2508
Tumor type 0.5460
Endometrial cancer 141 (19) 600 (81)
Colorectal cancer 262 (19) 1091 (81)
Lymphoma 147 (17) 719 (83)
Multiple Myeloma 22 (18) 98 (82)
Age at time of survey (mean±SD) 65.3 (11) 66.4 (12) 0.0333
Age at time of survey 0.0021
b60 years 174 (30) 600 (24)
60–69 years 185 (32) 815 (33)
≥70 years 213 (37) 1093 (44)
Years since diagnosis (mean±SD) 4.5 (2.5) 4.6 (2.5) 0.1302
Years since diagnosis 0.4358
1–5 years 357 (62) 1518 (61)
5–10 years 215 (37) 990 (39)
Gender 0.1877
Male 238 (42) 1111 (44)
Female 334 (58) 1397 (56)
Primary treatment
Surgery 399 (70) 1684 (67) 0.1430
Chemotherapy 182 (32) 866 (34) 0.2342
Radiotherapy 145 (25) 664 (27) 0.4223
Comorbiditya b0.0001
None 136 (24) 793 (32)
1 146 (26) 704 (28)
2+ 290 (51) 1011 (40)
Marital status 0.6499
Married 427 (76) 1839 (75)
Never married 108 (19) 495 (20)
Divorced/widowed 29 (5) 115 (5)
Education levelb 0.9869
Low 128 (23) 555 (23)
Medium 339 (62) 1491 (62)
High 85 (15) 387 (16)
Current occupation 0.7328
Employed 102 (19) 459 (19)
Not working/retired 448 (81) 1932 (81)
Socioeconomic status 0.0232
Low 137 (25) 517 (22)
Medium 244 (44) 965 (40)
High 170 (31) 915 (38)
a Adapted Self-administered Comorbidity Questionnaire (Sangha et al., 2003).
b Education: Low (no or primary school); Medium (lower general second-
ary education or vocational training); High (pre-university education, high
vocational training, university).
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istics (Table 1). Patients with unverifiable addresseswere youn-
ger, with more years since diagnosis, were less often treated
with surgery, and less often diagnosed with colorectal cancer.
Non-respondents were more often female, and were less often
treated with radiotherapy or chemotherapy.
In total, 3080 cancer survivorswere included in the final an-
alyses, of whom 572 (19%) had a Type D personality (Table 2).
No statistically significant differences were observed between
cancer survivors with andwithout a Type D personality in gen-
der, years since diagnosis, primary treatment, disease progres-
sion, educational level, marital status, current occupation and
socioeconomic status. However, cancer survivors with a Type
D personality were somewhat younger and reported to have
more comorbid diseases.
3.2. Generic quality of life
Colorectal and endometrial cancer survivors with a Type D
personality reported a poor general health, physical function-
ing, social functioning, role function-physical, role function-
emotional, and mental health as assessed with the SF-36 com-
pared to non-Type D survivors. In addition, they felt less vital
and reported more bodily pain (all P'sb0.0001; Table 3). The
Type D-related impairments in general health, social func-
tioning, role-function emotional, mental health and vitality
were also clinically relevant (Norman et al., 2003). Secondary
analyses showed that Type D personality was still significantly
associated with poor QoL after adjustment for depression. Sim-
ilarly, Type D personality was associated with poor QoL on all of
the SF-36 subscales when controlling for cancer type. Also, when
analyzing the SF-36 data for colorectal cancer and endometrial
cancer separately with respect to Type D personality, results
were similar as stated above indicating that Type D personality
was an independent correlate of a worse generic QoL.
Finally, we comparedmean scores on the SF-36 subscales be-
tween 1) those with a Type D personality, 2) those with a high
score (≥10) on negative affectivity but low score (b10) on social
inhibition, and3) thosewith a low score (b10) onnegative affec-
tivity in order to see whether Type D personality (defined by a
score ≥10 on both SI and NA) has additional value compared
to negative affectivity (defined by a score ≥10 on NA alone)
(Table 4). Results showed that those with a Type D personality
and those with a high score on negative affectivity only reported
worse scores on all SF-36 subscales compared to those with a
low score on negative affectivity (all P'sb0.0001). Importantly,
for the subscales role function-physical, vitality, social function-
ing, role function-emotional, and mental health, those with a
Type D personality reported significantly worse means scores
compared to those with a high score on negative affectivity but
low on social inhibition (all P'sb0.0001).
Multivariate logistic regression analyses showed that colo-
rectal and endometrial cancer survivors with a Type D person-
ality were at a significantly increased risk of an ‘impaired’
generic QoL as defined by a score N0.5 SD below the mean of
the SF-36 subscales (all ORs ranging between 1.88 and 3.46),
even after controlling for age, gender and comorbidity (Fig. 1).
In addition, the proportion of survivors with a Type D personal-
ity reporting an ‘impaired’ QoL on all the SF-36 subscales was
higher (41–64%) compared to the proportion of non-Type D
survivors with an impaired QoL (22–36%) (Fig. 1).3.3. Disease-speciﬁc quality of life
TypeD personalitywas associatedwith a poor cancer-related
QoL among lymphoma and multiple myeloma survivors
(Table 3), as indicated by poor physical-, role-, emotional-, and
social functioning (all P'sb0.0001), worse global health status
(Pb0.0001), and more somatic symptoms (all P's at least
b0.01). The Type-D related differences in emotional and social
functioning, global health status, and fatiguewere clinically rele-
vant (Norman et al., 2003). Secondary analyses showed that after
adjustment for depression, the difference between Type D and
non-Type D survivors in disease-specific QoL remained signifi-
cant for all EORTC-QLQ-C30 scales, except for the constipation
scale (P=0.05). Similarly, TypeDpersonalitywas also associated
with impaired disease-specific QoL when controlling for type of
cancer. Also,when analyzing the EORTCQLQ-C30data separately
for lymphoma patients with respect to Type D personality,
Table 3
Mean SF-36 and EORTC-QLQ-C30 scores, stratified by Type D personality.
Mean (±SD) P-value
Type D Non-type D
SF-36 (n=403) (n=1691)
General health 51.9 (19.8) 65.5 (21.5) b0.0001a
Physical function 61.9 (28.8) 71.1 (27.3) b0.0001
Role function-physical 49.3 (44.0) 69.8 (40.6) b0.0001
Bodily pain 66.9 (24.7) 77.2 (24.4) b0.0001
Vitality 52.5 (19.2) 68.3 (19.6) b0.0001a
Social functioning 69.8 (23.3) 84.1 (21.7) b0.0001a
Role function-
emotional
63.4 (43.9) 85.4 (31.6) b0.0001a
Mental health 62.2 (17.2) 80.5 (15.3) b0.0001a
EORTC-QLQ-C30 (n=169) (n=817)
Physical functioning 71.5 (23.3) 81.2 (19.6) b0.0001
Role functioning 66.1 (31.8) 79.8 (26.8) b0.0001
Emotional functioning 65.1 (25.0) 87.2 (18.8) b0.0001a
Social functioning 71.8 (28.3) 87.6 (21.7) b0.0001a
Global health
status/QoL
62.9 (20.8) 76.4 (19.0) b0.0001a
Fatigue 43.7 (27.8) 25.9 (24.8) b0.0001a
Nausea and vomiting 8.6 (18.2) 3.6 (11.8) b0.0001
Pain 28.2 (32.6) 15.2 (24.4) b0.0001
Dyspnea 24.4 (28.8) 16.3 (24.6) b0.0005
Insomnia 32.9 (33.6) 18.3 (27.6) b0.0001
Loss of appetite 14.0 (25.7) 7.0 (20.2) b0.0003
Constipation 12.1 (23.2) 7.4 (18.9) b0.0061
Diarrhea 12.0 (21.7) 5.8 (16.3) b0.0001
Financial impact 18.2 (28.7) 7.5 (18.9) b0.0001
The SF-36 was used to assess quality of life among colorectal and
endometrial cancer survivors.
The EORTC-QLQ-C30 was used to assess quality of life among lymphoma and
multiple myeloma survivors.
A higher score on the SF-36 scales and the EORTC-QLQ-C30 functional scales
and global QoL means better functioning and QoL, whereas a higher score on
the symptom scales mean more complaints.
Confounding background variables included for adjustment in these
analyses were determined a priori (Babyak, 2004) and chosen to be age
and comorbidity at time of questionnaire.
a Clinically relevant difference (Norman et al., 2003).
Table 4
Mean SF-36 scores for those with a Type D personality, those with a high
score (≥10) on negative affectivity, and those with a low score (b10) on
negative affectivity.
Mean (±SD) P-value
Type D High negative
affectivity
Low negative
affectivity
(n=403) (n=283) (n=1215)
SF-36
General
health
51.9 (19.8) 54.6 (21.8) 69.1 (20.2) Pb0.0001a
Physical
function
61.9 (28.8) 62.7 (30.0) 74.7 (25.2) Pb0.0001a
Role
function-
physical
49.3 (44.0) 55.4 (43.1) 75.0 (38.1) Pb0.0001b
Bodily pain 66.9 (24.7) 68.5 (26.7) 80.2 (22.8) Pb0.0001a
Vitality 52.5 (19.2) 56.5 (20.1) 71.9 (18.0) Pb0.0001b
Social
functioning
69.8 (23.3) 74.0 (24.2) 88.2 (18.0) Pb0.0001b
Role
function-
emotional
63.4 (43.9) 71.0 (40.9) 90.6 (25.4) Pb0.0001b
Mental health 62.2 (17.2) 65.9 (17.3) 84.9 (11.5) Pb0.0001b
Type D was defined by a score ≥10 on SI and NA; high NA was defined as a
score ≥10 on NA and b10 on SI; and low NA as a score b10 on NA,
irrespective of SI.
The SF-36 was used to assess quality of life among colorectal and
endometrial cancer survivors.
A higher score on the SF-36 scales indicates better functioning.
Confounding background variables included for adjustment in these
analyses were determined a priori (Babyak, 2004) and chosen to be age
and comorbidity at time of questionnaire.
a Type D personality and high negative affectivity alone are significantly
different from the low negative affectivity subgroup. There is no difference
between the Type D and high negative affectivity subgroup.
b All subgroups are significantly different with respect to SF-36 scores.
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sonality was an independent correlate of a worse generic QoL.
Multivariate logistic regression analyses showed that lym-
phoma andmultiple myeloma survivors with a Type D person-
ality had an increased risk to experience an ‘impaired’ QoL as
defined by a score N0.5 SD below the mean on all EORTC-
QLQ-C30 function scales (all ORs ranging 1.89 and 5.56), even
after controlling for age, gender and comorbidity (Fig. 1). In ad-
dition, the proportion of survivors with a Type D personality
reporting an ‘impaired’ QoL on the EORTC-QLQ-C30 function
scales was higher (35–59%) compared to the proportion of
non-Type D survivors with an impaired QoL (20–28%) (Fig. 1).3.4. Mental health
Cancer survivors with a Type D personality had higher levels
of anxiety (mean=7.8, SD 3.8) compared to non-Type D survi-
vors (mean=4.0, SD 3.5; Pb0.0001). Accordingly, clinically ele-
vated levels of anxiety, which was defined as a cut-off value of
≥8 on the HADS (Olsson et al., 2005; Zigmond and Snaith,
1983), were more prevalent in Type D than in non-Type D sur-
vivors (51% vs. 14%; Pb0.0001).Cancer survivors with a Type D personality had higher
levels of depression (mean=7.4, SD 4.0) compared to non-
Type D survivors (mean=3.9, SD 3.4; Pb0.0001) and clinically
elevated levels of depression (HADS cut-off value ≥8) were
more prevalent in Type D than in non-Type D (44% vs. 13%;
Pb0.0001) survivors. In comparison, the difference in depres-
sion between women and men was much smaller (22% vs.
17%; P=0.0031). The increased vulnerability of cancer survi-
vors with a Type D personality for anxiety and depression
was also evident across different types of cancer (Fig. 2).
Finally, 17% of Type D and 5% of non-Type D cancer survivors
reported to have had depression in the past 12 months
(Pb0.0001) as assessed with the Self-administered Comorbidity
Questionnaire (Sangha et al., 2003). Among those who reported
depression, 58% of Type D patients and 56% of non-Type D pa-
tients reported being treated for their depression.
4. Discussion
In this study, 19% of cancer survivors were classified as
having a Type D personality, which is quite comparable
with the prevalence of Type D in melanoma patients (22%)
(Mols et al., 2010a) and in the general population (13–24%)
(Aquarius et al., 2005; Denollet, 2005; Pedersen and Denollet,
2004). This percentage is however somewhat lower
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Fig. 1. Odds ratio's (95% CI) and proportion of cancer survivors that reported an impaired generic (SF-36) and disease-specific (EORTC-QLQ-C30) quality of life as
a function of Type D personality. ‘Impaired’ quality of life (coded as 1) was defined as a score N0.5 SD below the scale mean while ‘good’ quality of life (coded as 0)
was defined as all other scores (Norman et al., 2003). ORs associated with Type D personality, after adjustment for the a priori (Babyak, 2004) defined con-
founders age, gender and comorbidity. The SF-36 was used to assess quality of life among colorectal and endometrial cancer survivors. The EORTC-QLQ-C30
was used to assess quality of life among lymphoma and multiple myeloma survivors.
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lations (17–59%) (Denollet et al., 2010).
Cancer survivors with a Type D personality experienced a
worse QoL and mental health compared to survivors without
this personality type. In the majority of cases, these Type D-
related differences in QoL were clinically relevant, and
remained significant after adjustment for comorbid depres-
sive symptoms. This finding confirms previous results found
in a study among 562 melanoma survivors that also reported
that Type D personality had a distinct negative impact on
health status as measured by the SF-36 (Mols et al., 2010a).
Type D personality has also been associated with an impaired
QoL among a variety of other populations such as patient
with chronic tinnitus (Bartels et al., 2010), chronic heart fail-
ure outpatients (Schiffer et al., 2008b) and the general popu-
lation (Mols and Denollet, 2010b), suggesting that Type D
personality is a general vulnerability factor that adversely af-
fects QoL and mental health across populations and conditions.
This is the first study that documented impaired disease-
specific QoL in cancer survivors with a Type D personality,
but similar results have been reported in other chronic condi-
tions. Type D personality has been associated with the per-
ceived frequency and severity of side effects of continuous
positive airway pressure treatment in patients with obstruc-
tive sleep apnea (Brostrom et al., 2007), and a study of pa-
tients with peripheral vestibular disease showed that Type
D patients experienced their condition to be more disabling
than non-Type D patients (De Valck et al., 2007). A recent
prospective study of 503 post-myocardial infarction patients
also concluded that Type D personality is an independent
predictor of impaired disease-specific health status (Mols
et al., 2010b).Cancer survivors with a Type D personality experienced
increased levels of anxiety compared to non-TypeD survivors,
which is in accordance with the literature in cardiovascular
(Schiffer et al., 2008a; Spindler et al., 2007, 2009) and non-
cardiovascular (Mols and Denollet, 2010a) patients, and the
general population (Mols and Denollet, 2010b). Type D survi-
vorswere alsomore often depressed compared to non-Type D
survivors. In comparison, the gender difference in depression
was also significant but smaller than the Type D effect. Type D
personality thus seems to be a better predictor of depressive
symptoms among cancer survivors compared to a more
established socio-demographic risk factor. While these re-
sults should be confirmed in a large prospective study
among cancer survivors, it is known from other populations
that individuals with a Type D personality are more often de-
pressed compared to those without this personality type
(Barnett et al., 2009; Bartels et al., 2010; Mols et al., 2010b;
van den Broek et al., 2010). Although Type D personality and
depression seem to have much in common, they represent
different constructs (Denollet et al., 2010).
The present study has limitations that should be men-
tioned. Although we had information on the demographic
and clinical characteristics of non-respondents and patients
with unverifiable addresses, it remains unknown whether
non-respondents declined to participate in the study because
of poor health. Also, while the SF-36 was filled out by colorec-
tal and endometrial cancer survivors, the EORTC-QLQ-C30was
filled out by our cohorts of lymphoma and multiple myeloma
survivors, which limits comparison across different cancer
populations. In addition, this study was based on data from
four population-based longitudinal surveys on colorectal can-
cer, endometrial cancer, lymphoma, and multiple myeloma
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Fig. 2. Percentage of cancer patients with depression or anxiety, stratified by tumor and Type D personality. Figure legend: A HADS score of 8 was used as a cut-off
value for both depression and anxiety (Olsson et al., 2005; Zigmond and Snaith, 1983).
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populations. Also, the patient groups described in this study
are very different (e.g. with respect to disease stages and treat-
ment trajectories) making it seem arbitrary to include them
into one study. However, although these groups are very differ-
ent, the effect of Type D personality on their QoL and mental
health status are similar. How people deal with cancer and
how they perceive the situation can have a major impact on
their health status, regardless of the type of cancer. Finally, al-
though Type D personality is a stable construct (Kupper et al.,
2011; Martens et al., 2007), our cross-sectional analyses limit
the determination of causal association between Type D per-
sonality and QoL and mental health as baseline data on these
patient-reported outcomes are unknown. Future studies that
address this issue would be helpful in exploring this associationbetween Type D personality and patient-reported outcomes in
cancer patients.
Despite these limitations, the present study provides an im-
portant contribution to the limited data available on the impor-
tance of individual differences such as Type D personality
regarding the QoL and mental health of cancer survivors.
Since this is a large population-based study with a high re-
sponse rate, extrapolating these results to the larger population
of colorectal cancer, endometrial cancer, lymphoma, andmulti-
ple myeloma survivors seems justified. These results call for
further research on Type D personality among cancer survivors
followed over a longer period of time. In addition, potential un-
derlying mechanisms (e.g., poor adherence to treatment) that
may explain these Type-D related disparities in health status
should also be investigated among cancer survivors.
33F. Mols et al. / Journal of Affective Disorders 136 (2012) 26–34In conclusion, Type D personality was associated with
poor QoL and mental health status among survivors of endo-
metrial cancer, colorectal cancer, lymphoma and multiple
myeloma, even after adjustment for comorbid depressive
symptoms. Since our results confirmed the results of studies
among various patient populations (Mols and Denollet,
2010a) and the general population (Mols and Denollet,
2010b), Type D personality might be a general vulnerability
factor to screen for in clinical practice in order to identify
subgroups at risk for impaired QoL and mental health. Giving
special attention to cancer survivors with a Type D personal-
ity is important as they are more likely to experience a strong
negative impact of cancer on their QoL and mental health
which cannot be explained by socio-demographic or clinical
characteristics.
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